Recent studies were performed to detect the role of peptide hormone Preptin, as a novel bone-anabolic agent for the treatment of osteoporosis ( [19] and another one studied the effect of In vivo administration of Preptin and reported an increased bone area and mineralizing surface in adult mice. The gene discussed is IGF2; the disease is osteoporosis.